Related Experiment Video
Updated: Dec 22, 2025
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Ki-67 and Clinical Correlations in Patients with Resistant Prolactinomas
Chao Lu1, Yun Liu1, Zhiming Lu1
1Department of Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Objective:
Drug resistance is the main limitation for dopamine agonist therapy with prolactinoma. Transsphenoidal surgery is an additional operation that circumvents this limitation. To characterize distinctive clinical features of resistant prolactinoma in different levels of Ki-67, a retrospective analysis of 423 patients who were diagnosed and surgically treated at Shandong Provincial Hospital Affiliated to Shandong University from January 2007 to June 2017 was performed.
Methods:
Patients were subdivided into Ki-67≥3% group (High) and Ki-67<3% group (Low) according to Ki-67 labeling values.
Results:
Tumors in the High group were larger (P=0.001), associated with more frequent headaches and dizziness (P=0.004), more visual impairment (P=0.008), more polyuria and polydipsia (P=0.029), and had a higher percentage of invasion (P=0.003) than patients in the Low group. However, the prolactin normalization rate in the High group was significantly lower (P=0.042). More frequent recurrence was observed in the High group (P=0.018).
Conclusions:
These observations suggest the importance of investigating Ki-67 in patients with resistant prolactinoma. The treatment of resistant prolactinomas with higher level of Ki-67 is still a challenge.
